Intrasense
Research Intrasense (ALINS) on Bullrun: market cap EUR 20.01M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALINS
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyEUR
- Market capEUR 20.01M
- Financial periodFY2025
- RevenueEUR 2.99M
- Revenue growth28.4%
- Net income-EUR 10.81M
- Gross margin86.9%
Valuation Snapshot
latest market cap is EUR 20.01M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 2.99M | -EUR 10.81M | n/a | 86.9% | n/a | EUR 797.46K | EUR 9.30M | -EUR 6.46M |
| FY2024 | EUR 2.33M | -EUR 5.15M | -EUR 5.94M | 109.5% | -9.81 | EUR 886.51K | EUR 3.21M | EUR 4.08M |
| FY2023 | EUR 3.31M | -EUR 3.58M | -EUR 4.98M | 89.1% | -0.07 | EUR 4.55M | EUR 1.49M | EUR 7.29M |
| FY2022 | EUR 3.79M | -EUR 3.42M | -EUR 3.45M | 93.5% | -0.11 | EUR 1.41M | EUR 2.06M | EUR 2.01M |
| FY2021 | n/a | n/a | -EUR 1.46M | n/a | -0.04 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 20.01M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Intrasense
Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, an oncological imaging platform that automates the identification and measurement of lesions. Intrasense S.A.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Intrasense's market cap?
Intrasense's market capitalization is EUR 20.01M.
What does Intrasense do?
Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, an oncological imaging platform that automates the identification and measurement of lesions. Intrasense S.A. was incorporated in 2004 and is headquartered in Montpellier, France. Intrasense S.A. operates as a subsidiary of Guerbet SA.